vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与BRAND HOUSE COLLECTIVE, INC.（TBHC）财务数据对比。点击上方公司名可切换其他公司
BRAND HOUSE COLLECTIVE, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$103.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -9.6%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-26.8M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -21.0%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
本公司旗下拥有苏荷馆（Soho House），这是一个面向传媒、艺术与时尚领域从业者的国际私人会员俱乐部，旨在为创意行业从业者提供交流与休闲的专属私密空间。
PBYI vs TBHC — 直观对比
营收规模更大
TBHC
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出37.3%
-9.6%
自由现金流更多
PBYI
多$41.2M
$-26.8M
两年增速更快
PBYI
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $103.5M |
| 净利润 | — | $-3.7M |
| 毛利率 | 69.3% | 20.4% |
| 营业利润率 | 22.7% | -1.9% |
| 净利率 | — | -3.6% |
| 营收同比 | 27.7% | -9.6% |
| 净利润同比 | — | 51.8% |
| 每股收益（稀释后） | $0.26 | $-0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYITBHC
| Q4 25 | $75.5M | $103.5M | ||
| Q3 25 | $54.5M | $75.8M | ||
| Q2 25 | $52.4M | $81.5M | ||
| Q1 25 | $46.0M | $148.9M | ||
| Q4 24 | $59.1M | $114.4M | ||
| Q3 24 | $80.5M | $86.3M | ||
| Q2 24 | $47.1M | $91.8M | ||
| Q1 24 | $43.8M | $165.9M |
净利润PBYITBHC
| Q4 25 | — | $-3.7M | ||
| Q3 25 | $8.8M | $-20.2M | ||
| Q2 25 | $5.9M | $-11.8M | ||
| Q1 25 | $3.0M | $7.9M | ||
| Q4 24 | — | $-7.7M | ||
| Q3 24 | $20.3M | $-14.5M | ||
| Q2 24 | $-4.5M | $-8.8M | ||
| Q1 24 | $-4.8M | $10.1M |
毛利率PBYITBHC
| Q4 25 | 69.3% | 20.4% | ||
| Q3 25 | 77.7% | 16.3% | ||
| Q2 25 | 76.5% | 24.9% | ||
| Q1 25 | 77.1% | 30.3% | ||
| Q4 24 | 76.4% | 28.1% | ||
| Q3 24 | 63.9% | 20.5% | ||
| Q2 24 | 77.4% | 29.5% | ||
| Q1 24 | 75.5% | 32.0% |
营业利润率PBYITBHC
| Q4 25 | 22.7% | -1.9% | ||
| Q3 25 | 17.6% | -24.7% | ||
| Q2 25 | 12.7% | -12.9% | ||
| Q1 25 | 8.7% | 6.2% | ||
| Q4 24 | 22.6% | -2.1% | ||
| Q3 24 | 27.4% | -15.4% | ||
| Q2 24 | -4.6% | -8.2% | ||
| Q1 24 | -5.3% | 6.4% |
净利率PBYITBHC
| Q4 25 | — | -3.6% | ||
| Q3 25 | 16.2% | -26.6% | ||
| Q2 25 | 11.2% | -14.5% | ||
| Q1 25 | 6.5% | 5.3% | ||
| Q4 24 | — | -6.7% | ||
| Q3 24 | 25.2% | -16.8% | ||
| Q2 24 | -9.6% | -9.6% | ||
| Q1 24 | -11.0% | 6.1% |
每股收益（稀释后）PBYITBHC
| Q4 25 | $0.26 | $-0.16 | ||
| Q3 25 | $0.17 | $-0.90 | ||
| Q2 25 | $0.12 | $-0.54 | ||
| Q1 25 | $0.06 | $0.61 | ||
| Q4 24 | $0.40 | $-0.59 | ||
| Q3 24 | $0.41 | $-1.11 | ||
| Q2 24 | $-0.09 | $-0.68 | ||
| Q1 24 | $-0.10 | $0.80 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $6.5M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $-44.0M |
| 总资产 | $216.3M | $229.2M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYITBHC
| Q4 25 | $97.5M | $6.5M | ||
| Q3 25 | $94.4M | $3.6M | ||
| Q2 25 | $96.0M | $3.5M | ||
| Q1 25 | $93.2M | $3.8M | ||
| Q4 24 | $101.0M | $6.8M | ||
| Q3 24 | $96.7M | $4.5M | ||
| Q2 24 | $96.8M | $3.8M | ||
| Q1 24 | $107.2M | $3.8M |
总债务PBYITBHC
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | $64.0M | ||
| Q4 24 | $68.0M | $85.8M | ||
| Q3 24 | $79.3M | $61.4M | ||
| Q2 24 | $90.7M | $47.5M | ||
| Q1 24 | $102.0M | $34.0M |
股东权益PBYITBHC
| Q4 25 | $130.3M | $-44.0M | ||
| Q3 25 | $115.3M | $-35.2M | ||
| Q2 25 | $104.7M | $-16.2M | ||
| Q1 25 | $97.1M | $-19.0M | ||
| Q4 24 | $92.1M | $-27.1M | ||
| Q3 24 | $71.1M | $-19.7M | ||
| Q2 24 | $48.5M | $-5.5M | ||
| Q1 24 | $51.0M | $3.1M |
总资产PBYITBHC
| Q4 25 | $216.3M | $229.2M | ||
| Q3 25 | $202.9M | $221.9M | ||
| Q2 25 | $194.9M | $225.4M | ||
| Q1 25 | $196.2M | $242.2M | ||
| Q4 24 | $213.3M | $279.8M | ||
| Q3 24 | $220.7M | $266.2M | ||
| Q2 24 | $205.0M | $242.6M | ||
| Q1 24 | $214.1M | $250.6M |
负债/权益比PBYITBHC
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | 10.88× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-25.9M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $-26.8M |
| 自由现金流率自由现金流/营收 | 19.1% | -25.9% |
| 资本支出强度资本支出/营收 | 0.0% | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $-18.9M |
8季度趋势，按日历期对齐
经营现金流PBYITBHC
| Q4 25 | $14.4M | $-25.9M | ||
| Q3 25 | $9.7M | $-7.0M | ||
| Q2 25 | $14.1M | $-3.1M | ||
| Q1 25 | $3.6M | $19.8M | ||
| Q4 24 | $15.6M | $-12.6M | ||
| Q3 24 | $11.0M | $-12.7M | ||
| Q2 24 | $1.0M | $-13.7M | ||
| Q1 24 | $11.2M | $28.2M |
自由现金流PBYITBHC
| Q4 25 | $14.4M | $-26.8M | ||
| Q3 25 | $9.7M | $-7.4M | ||
| Q2 25 | $14.1M | $-3.6M | ||
| Q1 25 | $3.6M | $19.0M | ||
| Q4 24 | $15.6M | $-13.1M | ||
| Q3 24 | $11.0M | $-13.2M | ||
| Q2 24 | $1.0M | $-14.4M | ||
| Q1 24 | — | $26.7M |
自由现金流率PBYITBHC
| Q4 25 | 19.1% | -25.9% | ||
| Q3 25 | 17.7% | -9.8% | ||
| Q2 25 | 26.8% | -4.5% | ||
| Q1 25 | 7.7% | 12.8% | ||
| Q4 24 | 26.4% | -11.5% | ||
| Q3 24 | 13.7% | -15.2% | ||
| Q2 24 | 2.1% | -15.7% | ||
| Q1 24 | — | 16.1% |
资本支出强度PBYITBHC
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 0.6% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.1% | 0.5% | ||
| Q4 24 | 0.0% | 0.4% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | 0.0% | 0.8% | ||
| Q1 24 | 0.0% | 0.9% |
现金转化率PBYITBHC
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | 2.51× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.79× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
